Summary
Non‐invasive imaging techniques allow a quick and easy in vivo examination of the skin with different penetration depths and resolution depending on the applied technology.
Established methods such as dermoscopy and high‐resolution sonography of the skin have been an integral part of everyday life for decades. Additionally, new emerging techniques such as optical coherence tomography (OCT), reflectance confocal microscopy (RCM), and line‐field confocal OCT (LC‐OCT) have entered clinical practice. Multiphoton tomography and optoacoustic imaging are also considered promising new methods.
RCM and LC‐OCT can also be used ex vivo on freshly excised tissue, for example in Moh's surgery margin assessment.
The data generated by all imaging methods is ideal for the application of AI‐based algorithms to increase diagnostic accuracy and support experienced users.
All mentioned methods have preferred indications depending on their strengths and limitations, both in skin tumor diagnostics and in inflammatory, infectious and parasitic dermatoses. The following guideline provides an overview of the various devices and techniques, explains how each method works and provides the current study situation with indications and limitations of each procedure.
Keywords: Basal cell carcinoma, malignant melanoma, non‐invasive imaging, physical diagnosis, squamous cell carcinoma
ABOUT THIS GUIDELINE
This version of the guideline is a short version of the complete guideline, which is freely available as online supplement and at www.awmf.org. A complete list of references and an overview table on which the recommendations and statements of this guideline are based, as well as the conflicts of interest of the participating authors are provided in the long version or in the guideline report.
This first German guideline on imaging diagnostics for skin diseases was developed under the guidance of the German Dermatological Society (Deutsche Dermatologische Gesellschaft, DDG) and the Working Group Physical Diagnostics in Dermatology (Arbeitsgemeinschaft für Physikalische Diagnostik in der Dermatologie, ApDD) and is based on a systematic literature search and the consensus of the expert group. The guideline includes recommendations on technique, indications, evidence, and limitations of the various imaging methods.
Given that medicine is subject to a continuous process of development, any information, in particular on diagnostic and therapeutic procedures, can only reflect the state of knowledge at the time of printing the guidelines. The utmost care was taken with respect to the stated therapy recommendations as well as selection and the dosage of drugs. Nevertheless, users are advised to refer to the package leaflet or the manufacturer's summary of product characteristics and to consult a specialist in case of doubt. The user assumes responsibility for each diagnostic and therapeutic application, medication, and dosage. In this guideline, registered trademarks (protected trademarks) are not specifically identified. The absence of a respective reference does not imply that the trade name is not protected (free of charge).
REFLECTANCE CONFOCAL MICROSCOPY (RCM)
Technique
Reflectance confocal microscopy (RCM) is suited particularly well for the non‐invasive diagnosis of melanocytic and epithelial skin tumors. 1 Laser light of a selected wavelength is focused on a plane within the skin, where the light is reflected at interfaces with high refractive index (keratin, melanin, and collagen) and is then directed to a detector. Due to an upstream pinhole aperture, only signals from a predefined horizontal plane are used for imaging. While this approach allows for high‐resolution visualization of changes close to the surface with microscopic resolution of 1 to 3 µm in horizontal sections, it also limits the penetration depth into the skin.
Instruments
For reflectance confocal microscopy, instruments with one or multiple lasers are used as light sources. They can be used for both in vivo and ex vivo assessment of the skin. Given that the laser energy at tissue level is lower than 30 mW, there is no danger to the tissue being examined or to the human eye (laser class I).
Indications
Melanocytic lesions
Due to the high refractive index of melanin, melanocytic lesions can be visualized particularly well. Consequently, morphological image characteristics for the differentiation of benign and suspicious lesions have been established. 2 , 3
In this context, elimination of the normal epidermal architecture (atypical honeycomb pattern) and the normal structure of the dermal‐epidermal junction (DEJ, abrupt DEJ), lacking definition of dermal papillae (non‐edged papillae), presence of large, highly refractive cells with prominent nuclei in higher epidermal layers (round and dendritic pagetoid cells [Figure 1]), irregular nests of atypical melanocytes (dense and sparse nests, cerebriform nests), and small, highly refractive particles (inflammatory particles) are considered the most important criteria for malignant transformation. While diagnosis of amelanotic melanomas by RCM is more difficult, asymmetric, pigmented follicles, ≥ 3 atypical cells in five fields, and focal follicular extension of atypical cells at DEJ are considered key criteria for the differentiation from other skin tumors. 4
FIGURE 1.

Superficial spreading melanoma in various imaging techniques. (a) Clinical image; (b) horizontal in vivo reflectance confocal microscopy (VivaScope 1500, 750 µm × 750 µm, VivaScope GmbH, Munich, Germany); (c) ex vivo reflectance confocal microscopy of a nodular melanoma (VivaScope 2500M‐G4, VivaScope GmbH, Munich, Germany) showing dermal nests of atypical melanocytes in digital H&E mode; (d) vertical line‐field confocal optical coherence tomography (DeepLive, DAMAE Medical, Paris, France) showing pagetoid and dendritic cells (arrows).
Numerous studies show that RCM results in improved specificity in melanoma diagnostics compared to dermoscopy alone, especially in the case of unclear lesions. This has also been demonstrated in randomized controlled studies. 5 , 6 , 7 , 8 Ultimately, the use of RCM reduces the number of unnecessary excisions and enables early detection of even thin melanomas. Moreover, RCM can significantly reduce the number needed to excise (NNE), 8 , 9 thus reducing the costs for the healthcare system. 9
Basal cell carcinoma
RCM is also suitable for the examination of nonmelanoma skin cancer. 10 , 11 , 12 , 13 , 14 , 15 , 16
The following five main criteria have been described for diagnosis of basal cell carcinoma: elongated, monomorphic nuclei, polarization of these cells along one axis, pronounced inflammatory infiltrate, more and dilated vessels, and loss of epidermal honeycomb structure. 17 Islands of tumor cells with peripheral palisading in the dermis, separated from the connective tissue by a dark cleft, are also considered a characteristic feature (Figure 2). Histologically, this optical clefting corresponds to the accumulation of mucin. 18 In a large multicenter study, a high sensitivity of RCM of 100% and a specificity of 88.5% was shown for the diagnosis of basal cell carcinoma. 18
FIGURE 2.

Solid basal cell carcinoma. (a) Dermoscopic view (× 20); (b) in vivo reflectance confocal microscopy (VivaScope 1500, 750 µm × 750 µm, VivaScope GmbH, Munich, Germany) showing characteristic tumor islands; (c) ex vivo reflectance confocal microscopy (VivaScope 2500M‐G4, VivaScope GmbH, Munich, Germany) in digital H&E mode showing tumor cell aggregates; (d) optical coherence tomography (VivoSight, Michelson Diagnostics Ltd, Kent, UK) in vertical plane showing the tumor nodule (star); (e) line‐field confocal optical coherence tomography (DeepLive, DAMAE Medical, Paris, France) in 3D representation.
Actinic keratosis and squamous cell carcinoma
In RCM, actinic keratoses are characterized by a loss of normal honeycomb structure with atypia and pleomorphism of epidermal keratinocytes, parakeratosis, detached corneocytes in the stratum corneum, and solar elastosis, as well as blood vessel dilation. 19 , 20 , 21 , 22 , 23
Apart from the atypical honeycomb structure, Bowen's disease/squamous cell carcinomas in situ present with dyskeratosis and, typically, glomerular vessels. 24 , 25
Infectious and parasitic dermatoses
Given the high correlation with histopathological features, non‐invasive imaging shows also promising results in inflammatory and infectious skin diseases. 26 , 27
In infectious diseases, such as mycoses and parasitic dermatoses, RCM is suitable for direct pathogen diagnosis. Especially in superficial mycoses, such as tinea corporis, tinea cruris, and tinea manuum, and even in tinea incognita, which is difficult to differentiate clinically, direct detection of mycotic material in the epidermis is often achieved by RCM. 28 , 29 , 30 , 31 Apart from Trichophyton infections, Candida pseudofilaments and conidia 26 and Malassezia species with typical “spaghetti and meatball” equivalents have been detected by RCM in affected regions. 27
In case of onychomycosis, good visualization of mycelium and/or spores is ensured even in deeper nail regions, given that the optical character of the nail allows for a higher penetration depth. Hyphae and spores present as brightly reflective structures with typical morphology. 29 , 32 Accordingly, RCM achieves a high predictive value and a high specificity in diagnosis of onychomycosis 33 and has even shown superiority to many conventional detection methods in comparative studies. 29 , 32 , 34
Parasitic mites, such as Sarcoptes scabiei or Demodex folliculorum, can also be clearly identified. For example, RCM enables the rapid diagnosis of scabies with high sensitivity and specificity. 35 , 36 , 37 , 38 With respect to therapy monitoring of rosacea, RCM permits quantification of mite density that is superior to histology 38 , 39 and is also suitable for the diagnosis of other Demodex‐related diseases, such as Demodex blepharitis. 40
Inflammatory dermatoses
Psoriasiform dermatitis is strongly associated with thickening of the epidermis, whereas spongiotic dermatitis has the typical RCM features of epidermal spongiosis and vesicle formation. Prototypic diseases of psoriasiform dermatitis, such as plaque psoriasis and seborrheic dermatitis, can be further distinguished based on their morphological differences. 41 , 42 However, larger studies on sensitivity and specificity are currently not yet available.
Typical examples of spongiotic dermatitis include irritant and allergic contact dermatitis. Both can be differentiated from each other by RCM – by assessing the reaction of the stratum corneum, the presence of epithelial necroses, and different kinetics. 43 , 44 , 45 Unclear patch‐test results can thus be reliably classified experimentally, without the need for biopsies. 43 , 46 , 47 , 48
Limitations
In general, RCM requires detailed knowledge of skin histology and pathology for the correct interpretation of images. Therefore, this technique should be learned in training courses. The greatest limitation of RCM is the shallow penetration depth into the papillary layer of the dermis. Accordingly, all deeper dermal changes, for example in nodular melanomas, nodular basal cell carcinomas, or panniculitis, are missed in confocal diagnostics. It is only suitable for the diagnosis of diseases and tumors with characteristic changes in the epidermis and upper dermis. The relatively long measurement time and the small measuring field may also be limiting factors. Patients must be able to keep still for several minutes. Strongly protruding, sunken, keratotic, or weeping skin lesions are difficult to measure, given that surface changes may result in artifacts and shadowing effects.
Ex vivo REFLECTANCE CONFOCAL MICROSCOPY (Ex vivo RCM)
Technique
Ex vivo reflectance confocal microscopy (ex vivo RCM) is particularly well suited for examining freshly excised tissue in Moh's surgery margin assessment 15 and has fewer limitations in terms of penetration depth, given that the samples are mounted with the respective cutting surface. 49
Ex vivo RCM allows for histological examination of the skin within minutes without impairing subsequent, conventional histological examination. After fluorescence staining, the samples are examined by laser light analogous to in vivo RCM, 51 and images are generated using a reflection mode (RM) and/or fluorescence mode (FM). 52
Apart from the different reflective indices of cellular compartments, 53 the fluorescence can be used to create additional contrast that is determined by the histological structure and the properties of the used fluorophore.
While numerous fluorescent dyes have been described, 54 acridine orange has proven its worth in practice due to its good contrast between nucleus and cytoplasm and its minor bleaching. 50 , 55 Acquired images can be converted by the software into images mimicking hematoxylin and eosin (H&E) staining. 56
Spectrum of indications
Basal cell carcinoma
Ex vivo RCM is suited particularly well for the histological diagnosis of basal cell carcinoma. In digital staining, tumor cell proliferates present with identical morphology compared to classical H&E staining (Figure 2). 57 This can be used both for confirmation by biopsy and in Moh's surgery.
Due to the short time required to obtain the histological image, ex vivo RCM presents an alternative to conventional (cryostat‐based) Moh's surgery margin assessment. Moreover, in contrast to classical Moh's surgery, ex vivo RCM does not result in tissue loss. In several studies, sensitivity and specificity of the method have been reported as 73%–100% and 90%, respectively. 58 , 59 , 60 , 61
Squamous cell carcinoma, Bowen's disease, and actinic keratosis
The visualization of cutaneous squamous cell carcinomas by ex vivo RCM with digital staining is similar to conventional H&E sections; however, tumor cells are less eosinophilic while hyperkeratosis results in stronger reflection. Nuclear staining with acridine orange permits detection of nuclear pleomorphisms and atypical mitotic figures. An invasive growth pattern is clearly identified. 55 Given the detailed visualization of nuclear pleomorphisms and mitotic figures, the morphology of actinic keratosis and Bowen's disease is identical to H&E sections, and these entities are well differentiated from squamous cell carcinoma. 62
Melanocytic tumors
The parameters for classification of melanocytic tumors were defined already in 2017, analogous to in vivo RCM. 53 Overall, the assessment appears to be difficult due to the strong reflection of melanin. Therefore, while non‐pigmented melanocytic nevi can certainly be identified as such, 49 the technique is not (yet) suitable for the reliable differentiation of melanomas and nevi.
Inflammatory dermatoses
Through application of pattern analysis according to Ackermann, 63 ex vivo RCM enables an initial assessment of inflammatory dermatoses within a few minutes. For this purpose, the arrangement of the inflammatory cellular infiltrate in the dermis (superficial, deep, perivascular, perifollicular, interstitial, lichenoid) or in adipose tissue (septal versus lobular panniculitis) is assessed. 64
Additional features of inflammatory dermatoses, such as spongiosis or acanthosis, are also clearly identified. 64 In blistering dermatoses, intraepidermal and subepidermal blister formation can be distinguished. In terms of perspective, the technique may also be used for direct immunofluorescence analysis on wet mounts. 65 The examined biopsies can subsequently be processed without tissue loss for conventional histology and immunohistochemistry. 63
Limitations
In addition to the optimization of sample preparation, staining, and technical image generation, current challenges include, in particular, the correct interpretation of the microscopic ex vivo image. 66
Imaging of large tissue samples may be challenging, given that the freshly excised, unfixed tissue sample should not be thicker than a few millimeters and often requires macroscopic manual trimming. 67
Due to variations in sample thickness, density, and quality, it is also necessary to adjust the pressure applied during tissue mounting as evenly as possible, to ensure a level tissue surface. 49 , 51
Irregularities in tissue surface caused by, for example, sample contamination, incomplete contact to the slide due to air bubbles, and insufficient ultrasound gel as medium for the water immersion lens, may result in the artifacts described above and limit image interpretation. 68
For tissue portions that are not visualized, serial imaging at different penetration depths followed by fusion can minimize artifacts and facilitate automatic pattern recognition using artificial intelligence (AI). 69
Given that blurry staining is often observed when analyzing frozen sections, ex vivo RCM on fresh tissue is recommended. 70
Limitations of the utilization of AI in ex vivo RCM include technical challenges such as insufficient tumor identification by AI in cases of unclear tumor borders, and unequal or insufficient contrast, especially in cases of coinciding dense inflammatory infiltrates. In addition, increased error rates are observed in the differentiation of tumor portions and skin appendages. In ex vivo RCM, suboptimal flattening of the tissue prior to scanning results in many artifacts and will, therefore, impede the interpretation not only for experts but also for AI. 71
OPTICAL COHERENCE TOMOGRAPHY (OCT)
Technique
In optical coherence tomography (OCT), light beams are sent into the tissue, usually with a superluminescent diode, 72 and the differences in transit time of the reflected light portions are recorded. The coherence length of the light source defines the axial resolution of 3–15 µm and the lens optics defines the lateral resolution of up to 15 µm. 73 Wavelength and, indirectly, light scattering by the skin limit the penetration depth into the skin to 1–2 mm. After amplification of the signal intensity, vertical 2D‐images can be generated based on a logarithmic grayscale or false color scale. 73 , 74 Structural or conventional OCT images are similar to images of histological sections. In addition, some instruments are equipped with dynamic OCT software. These are also referred to as angiographic or dynamic OCT (D‐OCT). D‐OCT is based on the principle of speckle‐variance OCT. This means that the software shows moving particles as red superimposition over the gray‐white structural OCT image. 75
Indications
Basal cell carcinoma
Apart from its importance in the diagnosis of basal cell carcinoma, OCT allows conclusions to be drawn on the underlying histological subtype by visualization of specific epidermal and dermal morphologies: In vertical and en face view of structural OCT imaging, nodular basal cell carcinomas present as a dermal hypo‐reflective ovoid structure with hypo‐reflective clefting and a hypo‐reflective rim (Figure 2). 76 The nests are always found near hair follicles and are typically associated with the hair shaft. 77 In the hyper‐reflective compact connective tissue rim of the tumor nests, elongated, oval, and partly branched vessels with a diameter of up to 300 µm are found. 77 Important criteria of superficial basal carcinomas include hypo‐reflective nests or ovoid structures originating from the epidermis with hypo‐reflective protrusions into the dermis. 76 The vessels present without branches, thin (< 40 µm), short (< 80 µm) and with a loose helical course in the area of the DEJ. 77 Typical of sclerodermiform basal cell carcinoma is a racemose presentation with multiple nodular structures separated from the epidermis or smaller aggregating groups of nests. 76 Typically, the tumor nests are surrounded by dilated vessels. 77
Actinic keratosis and squamous cell carcinoma
OCT may also be a suitable procedure for diagnosis of cutaneous squamous cell carcinoma and in the differentiation of squamous cell carcinoma, actinic keratosis, and Bowen's disease. 78 Actinic keratoses are characterized by morphological criteria, such as abnormal architecture of the epidermal cellular layers, thickened epidermis, and evidence of epidermal hyper‐reflective morphology consisting of streaks and dots. 79 If squamous cell carcinoma is suspected, the integrity of the DEJ should be assessed initially. If this cannot be confirmed reliably or completely, invasive infiltration by squamous cell carcinoma should be suspected. This is corroborated if hyper‐reflective epidermal tumor infiltration with blurring of DEJ or epithelial periadnexal infiltration is observed. 80
Melanocytic lesions (nevi and melanomas)
Structural OCT is of minor significance in the diagnosis of melanocytic lesions, given that unambiguous discrimination of nevi and malignant melanomas is impossible due to the insufficient resolution of structural OCT. 81 , 82
Another criterium to differentiate between benign and malignant melanocytic lesions is the assessment of the vascular pattern. Welzel et al. could show by means of D‐OCT that melanomas have more blood vessels than the surrounding healthy skin, and that these also exhibit a chaotic vascular pattern. 83 The features “atypically formed and irregularly distributed vessels, increased vessel density and increased vessel diameter” were significantly associated with high‐risk melanomas and metastatic melanomas. 83 Moreover, it was shown that atypic vessels are positively correlated with the Breslow index. 84
Inflammatory and infectious skin diseases
Inflammatory and infectious dermatoses associated with changes in epidermis and circulation can be examined by (D‐)OCT. In contrast to the assessment of nonmelanoma skin cancer (NMSC), there is currently little evidence for the examination of most inflammatory and infectious skin diseases, and the indications are rather experimental in nature.
Limitations
The most important limitation of OCT is the low resolution at the expense of the high penetration depth due to physical restrictions. Given the low resolution, individual cells cannot be visualized. Moreover, structural differentiation of melanocytic lesions is not possible. This limitation has now been overcome by the development of OCT into line‐field confocal optical coherence tomography (LC‐OCT). For optimal measurement without motion artifacts, a stable positioning of the patient is required to avoid movement by patient and investigator. Dynamic motion artifacts manifest as horizontal lines. The best results are achieved by stabilizing the OCT instrument during measurement with both hands. No preparation of the skin with gel or oil is required for OCT examination. The measurement is therefore fast, taking approximately 30 seconds without dynamic mode and 60 seconds with D‐OCT.
LINE‐FIELD CONFOCAL OCT (LC‐OCT)
Technique
Line‐field confocal OCT (LC‐OCT) combines the principles of OCT and RCM, thus enabling high‐resolution (1–2 µm) visualization of the skin down to the mid‐dermis (approximately 500 µm). The instrument consists of a two‐beam interference microscope with a continuous laser source with a wavelength of 800 nm and a line scan camera as photodetector.
In detail, LC‐OCT is based on time‐domain OCT (TD‐OCT) generating multiple, parallel A‐scans from the skin surface down to a depth of 500 µm for the acquisition of B‐images while the instrument is constantly refocusing. Dynamic live focusing of B‐scans allows for a high frame rate, lateral (1.3 µm) and axial (1.1 µm) resolution. The images are black‐gray‐white. Their contrast is generated by the varying degrees of reflection of natural chromophores in the skin, such as keratin and melanin. For example, due to the relatively high refractive index compared to air and water, pigmented cells are depicted as very bright, contrary to the dark cytoplasm, which is rich in water. The images are generated in real time in three modes: vertical (en coupe) as in OCT and histology, horizontal (en face) as in RCM and dermoscopy, and 3D. Video recordings are also possible. Navigation on the instrument is controlled by a dermoscopic camera to facilitate the exact localization of the scan.
Given that the incorporated laser corresponds to laser classification 1M according to EN 60825‐1, it is approved for use without special protective equipment for patients, including children and pregnant women.
Indications
Basal cell carcinoma
LC‐OCT allows for morphological diagnosis and subtyping of basal cell carcinomas: Nodular basal cell carcinomas show atypic keratinocytes, altered DEJ, tumor nests in the dermis, hypo‐reflective clefting, prominent vascularization, and white hyper‐reflective stroma, whereas superficial basal cell carcinomas present with thickening of the epidermis due to tumor nodes with string of pearl pattern, and sclerodermiform basal cell carcinomas with elongated hypo‐reflective tumor strands surrounded by bright collagen (shoal of fish pattern) (Figure 2). 85 , 86 , 87
Field cancerization
In numerous studies, various specific stages of keratinocyte tumors have been analyzed by LC‐OCT. The focus was on the morphology of keratinocytes and the architecture of epidermis and DEJ. 88 , 89 , 90 Typical features shown with LC‐OCT include hyperkeratosis/parakeratosis, disruption of stratum corneum, broadened epidermis, basal and suprabasal keratinocyte atypia, dilated vessels, and collagen alterations. While squamous cell carcinomas present with an interrupted dermal‐epidermal junction zone as well as ulceration and keratin plugs, the DEJ is usually clearly identified in actinic keratoses and Bowen's disease. Based on the basal growth pattern of keratinocytes, LC‐OCT is also able to classify actinic keratoses reproducing the histological PRO classification. 91
Melanocytic lesions
LC‐OCT provides the opportunity to assess melanocytic lesions. Similar to RCM, the high resolution enables analysis of individual cells and may thus facilitate differentiation of nevi and melanomas. 92 , 93 , 94 , 95 Benign nevi show wavelike structures in papillary and reticular dermis corresponding to melanocytic strands/nests (wave pattern). 92 Irregular honeycomb patterns, pagetoid growth of large, round hyper‐refractive cells in the epidermis, and absence of well‐defined, homogenous dermal nests are characteristic for the diagnosis of melanomas (Figure 1). In one study, LC‐OCT showed high sensitivity and specificity for the diagnosis of melanomas, although differentiation from dysplastic nevi is still unclear. 93
Inflammatory dermatoses
Due to its fast cellular resolution, LC‐OCT facilitates visualization of epidermis, DEJ, and dermis to a depth of 500 µm. In inflammatory dermatoses, it may enable correlation with in vivo histopathology. The best‐studied skin diseases include autoimmune bullous dermatoses, contact eczema, and psoriasis, although the studies performed so far should be seen as preliminary. Characteristic features, such as spongiosis and vesicle formation, can be depicted. While inflammatory cells appear as refractile elements, subtyping is usually not possible. Given that the level of split formation can be determined intuitively, however, this can be used successfully for the non‐invasive diagnosis of pemphigus foliaceus, pemphigus vulgaris, and bullous pemphigoid if clinically suspected. 96 In addition, there have been anecdotal reports for the use in pustular dermatoses. 97 Plaque psoriasis is characterized by thickening of stratum corneum and epidermis, elongated rete ridges, and hypo‐refractive, elongated dermal papillae in LC‐OCT. Munro's microabscesses in the form of subcorneal conglomerates of hyper‐refractive cells are less common. In contrast, eczemas are predominantly characterized by thickened and disrupted stratum corneum with alternating hypo‐ and hyper‐refractive layers as well as spongiosis and vesicle formation. 98 Given that systematic studies on these topics are not yet available, diagnostic criteria need to be further defined and standardized.
Limitations
While LC‐OCT is very intuitive compared to, for example, RCM, the correct interpretation of images requires detailed knowledge of histology and pathology of the skin. Accordingly, this technique should be learned in training courses. The resolution is almost cellular, although nosological classification of individual cells is sometimes difficult. This applies especially to inflammatory cells. Due to the penetration depth to the mid‐dermis, deeper dermal changes – for example, nodular melanomas, nodular basal cell carcinomas, or panniculitis – are not adequately assessed, especially in thicker lesions. Similar to histology or dermoscopy, the method remains user‐dependent.
MULTIPHOTON TOMOGRAPHY
Technique
Multiphoton tomography (MPT) is based on the principle of fluorescence excitation of endogenous molecules by two or more photons. In contrast to single photon microscopy where fluorophores are excited by relatively high‐energy, short‐wave radiation, imaging by MPT is based on energy emissions by means of long‐wave radiation in the near infrared spectrum. 99
Epidermal and dermal structures are visualized in high resolution by autofluorescent molecules, such as keratin, melanin, elastin, porphyrins, as well as free and protein‐bound NADH, and the phenomenon of second harmonic generation (SHG). Integrated Fluorescence Lifetime Imaging (FLIM) allows also for the analysis of the cellular metabolic state and molecular finger prints. 100 , 101 MPT produces images of horizontal sections, but reconstruction of these images also permits three‐dimensional tissue assessment. 102
A particular advantage of MPT is the intravital analysis at high resolution without requirement for prior staining or labeling of tissue. In this respect, by eliminating the artifacts induced by these methods, such as shrinking or influx of fluid into the intracellular space, MPT is superior to conventional histology.
Indications
Actinic keratosis
Histopathologic characteristics of actinic keratosis in MPT include acanthosis, pleomorphic keratinocytes, shifted nucleus‐cytoplasm ratio in favor of nuclei, as well as reduced cell density and increased, irregular intracellular spaces. 103 AK cells present with heterogeneous fluorescence patterns and forms. 103 In addition, increased collagen content below the AK with surrounding solar elastosis of sun‐exposed skin can be visualized. 103 , 104 , 105
Squamous cell carcinoma
In MPT, squamous cell carcinomas present with hyperkeratosis in all epidermal layers. 103 Fluorescent cell compartments in corneocytes and keratin bundles corresponding to histological keratin pearls of squamous cell carcinoma are also depicted. 106 , 107 The microscopic changes of actinic keratosis, such as increased nucleus‐cytoplasm ratio and reduced cell density in the individual epidermal layers, are significantly more pronounced in squamous cell carcinoma. 103
Basal cell carcinoma
In MPT, basal cell carcinoma is characterized by a loss of organization of the epidermal layers and monomorphic, elongated tumor cells and nuclei densely packed and polarized in one or two directions. 108 At an excitation of 760 nm, nests of tumor cells can be visualized by surrounding collagen and elastin fibers in parallel organization. Tumor cells have a longer fluorescence lifetime than the surrounding matrix. 109 Given that tumor cells cannot be visualized at a wavelength of 800–820 nm, the extracellular matrix appears surrounded by dark dermal spaces (phantom islands). 108 , 109
Melanoma
Typical histopathological alterations of melanoma, such as immigrated melanocytes in the epidermis and enlarged intracellular spaces with blurry demarcation to melanocytes can be depicted on MPT images. 110 Moreover, pleomorphic, atypical melanocytes, cellular fragment and dendritic cells with highly fluorescent dendrites are present in all epidermal layers. 110 , 111 Dimitrow et al. described the in vivo diagnosis of melanoma by MPT with a sensitivity of 75% and a specificity of 80%. 110 The differentiation from melanocytic nevi by multiphoton tomography has been examined in several studies. In contrast to melanoma, these are characterized by monomorphic and clearly defined cells and a regular cellular architecture. 112 No significant difference between melanocytic cells in melanoma and melanocytic nevi has been observed with respect to fluorescence lifetime. 113
Inflammatory dermatoses
Atopic dermatitis
MPT can visualize the characteristic histological features of atypical dermatitis, such as thickened epidermis and enlarged intracellular spaces caused by inflammation‐related edemas. 114 Compared to classical histology, MPT proves its advantage by the absence of artifacts caused by embedding and staining procedures. Apart from these pathological changes, MPT can reveal the reorganization of mitochondria with perinuclear accumulation. 114 , 115 , 116 Determination of the fluorescence lifetime ratio for free and protein‐bound NADH permits the calculation of the so‐called mean fluorescence lifetime corresponding to the cellular metabolic state. 117 , 118 , 119 Huck et al. have demonstrated a reduced taum in the stratum granulosum of patients with atopic dermatitis correlating with the severity of the disease. In addition, they could demonstrate a reduced taum in non‐lesional skin of patients with atopic dermatitis whose subclinical inflammatory metabolism remains usually occult in classical histology. 114
Psoriasis vulgaris
Psoriasis vulgaris presents with acanthosis, parakeratosis and Munro's abscesses in MPT. 120 In addition, a characteristic, punctuated fluorescence pattern is observed below the stratum corneum of psoriasiform plaques, probably caused by the parakeratosis of psoriasis. 121 Elongated and dilated papillae have been described using MPT. 121 Zurauskas et al. examined the fluorescence decay times of psoriasis patients with MPT and could demonstrate a correlation with the Psoriasis Area and Severity Index (PASI). 122 This was facilitated by fully automated analysis of optic biopsies.
Limitations
In general, MPT requires extensive histopathological knowledge. Image interpretation is often impeded by the horizontal presentation of sections. Another limitation is the low penetration depth of approximately 200 µm. 101 Assessment of severely wrinkled, sunken, protruding, hyperkeratotic, or weeping lesions is limited. Due to the high‐resolution images on the subcellular level, movement artifacts should be minimized.
Another limitation of MPT is the high cost of purchase and associated maintenance. A darkened and temperature‐controlled room is required for measurements. Older MPT systems are limited by their size and the restricted motion of the optical arm. The newer generations of MPT, with a more compact, cooling‐free design and a more mobile arm, are more practical for everyday clinical use. 123 , 124
ADDITIONAL TECHNIQUES
Optoacoustic techniques
In optoacoustic imaging, ultrashort light impulses in the visible to infrared spectrum are absorbed by respective biomolecules in tissue (for example, melanin, hemoglobin, lipids, protein, water) and generate ultrasound waves by local thermoelastic expansion (photoacoustic effect). Subsequently, algorithms translate the detected sound waves into a three‐dimensional presentation of macroscopic, mesoscopic, or microscopic resolution. 125 , 126 , 127
Multispectral optoacoustic tomography (MSOT)
Multispectral optoacoustic tomography (MSOT) has a high penetration depth with good resolution (penetration depth > 10 mm, lateral resolution 100–500 µm, axial resolution 100–500 µm). 128 MSOT has already provided promising results in various dermatological areas, such as detection of melanoma metastases in sentinel lymph nodes (SLN), size determination of (nonmelanoma) skin cancer, or determination of inflammatory activity in psoriasis arthritis. Instruments with a CE certificate are already commercially available for research purposes.
Raster‐scan optoacoustic mesoscopy (RSOM)
Raster‐scan optoacoustic mesoscopy (RSOM) combines the advantages of deeply penetrating MSOT and high‐resolution optoacoustic microscopy (OAM) and provides a particularly good ratio of penetration depth and image resolution (penetration depth 0–10 mm, lateral resolution < 100 µm, axial resolution 10–100 µm). 128 RSOM has the potential to complement non‐invasive diagnostics and microscopically controlled surgery not only in the field of chronic inflammatory dermatoses, but also in melanocytic neoplasms. 129 , 130 , 131 , 132
Limiting aspects of RSOM imaging include the long acquisition time, the susceptibility to motion (for example, breathing), and the low penetration depth restricting the image quality at higher depth. Moreover, penetration depth and thus image quality is restricted in skin types V and VI according to Fitzpatrick, due to the strong absorption by melanin. In addition, dimensions and flexibility of the instruments impede measurements in difficult‐to‐reach, uneven sites of the body and in patients with restricted mobility. 126 , 133
Optoacoustic microscopy
While optoacoustic microscopy provides the highest resolution of the three procedures mentioned, it is associated with a lower penetration depth (penetration depth 1–2 mm, lateral resolution < 50 µm, axial resolution < 30 µm). 128 So far, OAM has only been used in experimental studies. In other disciplines (for example, ophthalmology, cardiology, gastroenterology, and gynecology), application of OAM has been investigated in preclinical studies. 134 , 135 , 136
Multispectral analysis
Multispectral analysis acquires tissue reflection data in visible to infrared wavelengths and allows for precise quantification and analysis of spectral, colorimetric, and spatial features of skin components.
As a sensitive, fully automated, non‐invasive, and user‐friendly imaging method, multispectral analysis may present a potential, additional screening instrument. Given the low specificity and user‐dependent image quality, multispectral analysis is currently not used in daily clinical routine. 137 , 138 , 139 , 140
Raman spectroscopy
Raman spectroscopy analyzes the inelastic light scattering of molecules and solid objects. Scientifically, the selective, molecular presentation of skin structures or substances is used for the diagnosis of skin lesions (especially melanomas) and the quantitative analysis of dermal water content, photoaging, topical pharmacokinetics, cosmetics, and visualization of tattoo pigments. 141 , 142 , 143 , 144
Limiting factors for routine clinical and scientific use are the long acquisition time, limited image quality, and complex technology associated with relatively high costs. 144
Micro‐electrical impedance spectroscopy (MIS)
Micro‐electrical impedance spectroscopy (MIS) is not an optical procedure, but measures tissue‐specific resistance (impedance). The result is used to calculate an electrical impedance score (EIS 0–10), which has been evaluated in various studies. This score correlates with certain probabilities of malignancy of keratinocytic or melanocytic lesions. For use in nonmelanoma lesions, seborrheic keratoses, in particular, have to be excluded clinically by other means, to prevent an unnecessarily high number of false positive, elevated EIS. If seborrheic keratoses and inflammatory lesions are excluded clinically or by dermoscopy, MIS may present a valuable decision‐making tool in clinical routine.
Laser‐induced plasma spectroscopy (LIPS)
Laser‐induced plasma spectroscopy (LIPS) is a new procedure for analyzing the potential malignancy of suspicious lesions. Similar to MIS, the results are assessed via a score which may be helpful for further management of the lesion. Here, a nanosecond impulse from a neodymium‐YAG laser is used to generate a microplasma from the lesion, which is then analyzed spectroscopically using AI‐based software. The technique is painless on the skin and non‐invasive. Three measurements are performed per lesion. In other medical and physical areas, LIPS has already been used as a fast and precise tool (hepatic carcinomas, colorectal carcinomas, breast cancer). The plasma changes (among others, calcium, zinc, and copper concentration) correlate with cell proliferation, apoptosis, and differentiation. 145
COMPARISON OF METHODS AT A Glance
Table 1 provides an overview of the presented imaging techniques including technical specifications, primary indications, and equipment costs.
TABLE 1.
Overview of innovative, non‐invasive imaging techniques for dermatological diagnostics.
| Resolution | Penetration depth | Duration of measurement | Image section (horizontal, vertical, 3D) | Image interpretation | Equipment costs | Primary indication (melanocytic, NMSC, inflammatory) | |
|---|---|---|---|---|---|---|---|
| In vivo RCM | 1–3 µm | Up to 250 µm | 2–5 min | Horizontal | Detailed knowledge of dermatopathology required; training courses | From 70,000–185,000 € (depending on equipment) | Epithelial and predominantly melanocytic tumors with higher resolution |
| Ex vivo RCM | 1–3 µm | Up to 250 µm | < 1–5 min (depending on tissue size) | Horizontal and vertical | Detailed knowledge of dermatopathology required | From 249,000 € | Moh's surgery margin assessment of fresh tissue derived from epithelial and melanocytic tumors; other disciplines (e. g., gynecology and urology) |
| OCT | 10–15 µm | Up to 1.5 mm | 0.5–1 min | Horizontal and vertical | Detailed knowledge of dermatopathology required | From 85,000 € | Epithelial tumors with higher penetration depth |
| LC‐OCT | 1–3 µm | Up to approx. 500 µm | 2 min | Horizontal, vertical, 3D, and video recordings | Detailed knowledge of dermatopathology required; training courses | From 150,000 € | Epithelial and melanocytic tumors with higher resolution |
| MPT | 0.5–2 µm | Up to 200 µm | 5–15 min | Horizontal | Detailed knowledge of dermatopathology required; training courses required for interpretation | From 290,000–325,000 € (depending on equipment) | Inflammatory skin diseases (suspected atopic dermatitis and psoriasis), acute and chronic wounds, epithelial/melanocytic tumors |
| Optoacoustic |
Depending on method, < 1 µm to 100–500 µm lateral and axial |
More than 10 mm | 1–15 min | 3D | Detailed knowledge of dermatopathology required; training courses required for interpretation; user‐dependent |
MSOT: 350,000–500,000 € RSOM: 130,000–150,000 € |
Melanoma metastases in sentinel lymph nodes; size determination of skin tumors; inflammatory activity and monitoring of therapy in inflammatory diseases |
| Multispectral analysis | 20 µm | Up to 2.5 mm | 3 min | Horizontal | Computer‐assisted imaging enables classification of melanocytic lesions | Currently, not commercially available. | Additional screening tool (no routine use in clinical practice yet) |
| Raman spectroscopy | Depending on method, up to a few µm | Depending on wavelength, up to several hundred µm | 3–10 min | Raman spectrum | Spectral analysis compared with reference spectra; user‐dependent; training courses required | Currently, not commercially available | Epithelial/melanocytic tumors |
| Non‐optical procedures | Output mode | ||||||
| Micro‐electrical impedance spectroscopy | – | To upper dermis | 3–5 min | EIS | Impedance analysis compared to normal tissue | From 6,900 € | Epithelial/melanocytic tumors |
| Laser‐induced plasma spectroscopy | – | Epidermal lesions | 3–5 min | LIPS score | Plasma spectral analysis compared to normal tissue | From 42,000 € | Epithelial/melanocytic tumors |
Abbr.: In vivo RCM, in vivo reflectance confocal microscopy; Ex vivo RCM, ex vivo reflectance confocal microscopy; OCT, optical coherence tomography; LC‐OCT, line‐field confocal optical coherence tomography; MPT, multiphoton tomography; 3D, three‐dimensional; EIS, electrical impedance score; LIPS, laser‐induced plasma spectroscopy.
CONFLICT OF INTEREST STATEMENT
See long version of the guideline at www.awmf.org.
ACKNOWLEDGMENT
Open access funding enabled and organized by Projekt DEAL.
Deußing M, Schuh S, Thamm J, et al. S1 guideline for imaging diagnostics for skin diseases. JDDG: Journal der Deutschen Dermatologischen Gesellschaft. 2025;23:1616–1632. 10.1111/ddg.15883
AWMF registry number: 013‐076, 2024
Validity of guideline: The present guideline is valid until September 30, 2029.
Participating societies:
‐German Dermatological Society (Deutsche Dermatologische Gesellschaft, DDG)
‐Working Group Physical Diagnosis in Dermatology (Arbeitsgemeinschaft für Physikalische Diagnostik in der Dermatologie, ApDD)
REFERENCES
- 1. Rajadhyaksha M, Grossman M, Esterowitz D, et al. In vivo confocal scanning laser microscopy of human skin: melanin provides strong contrast. J Invest Dermatol. 1995;104(6):946‐952. [DOI] [PubMed] [Google Scholar]
- 2. Pellacani G, Vinceti M, Bassoli S, et al. Reflectance confocal microscopy and features of melanocytic lesions: an internet‐based study of the reproducibility of terminology. Arch Dermatol. 2009;145(10):1137‐1143. [DOI] [PubMed] [Google Scholar]
- 3. Scope A, Benvenuto‐Andrade C, Agero AL, et al. In vivo reflectance confocal microscopy imaging of melanocytic skin lesions: consensus terminology glossary and illustrative images. J Am Acad Dermatol. 2007;57(4):644‐658. [DOI] [PubMed] [Google Scholar]
- 4. Pizzichetta MA, Polesel J, Perrot JL, et al. Amelanotic/hypomelanotic lentigo maligna: Dermoscopic and confocal features predicting diagnosis. J Eur Acad Dermatol Venereol. 2023;37(2):303‐310. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5. Pezzini C, Kaleci S, Chester J, et al. Reflectance confocal microscopy diagnostic accuracy for malignant melanoma in different clinical settings: systematic review and meta‐analysis. J Eur Acad Dermatol Venereol. 2020;34(10):2268‐2279. [DOI] [PubMed] [Google Scholar]
- 6. Lan J, Wen J, Cao S, et al. The diagnostic accuracy of dermoscopy and reflectance confocal microscopy for amelanotic/hypomelanotic melanoma: a systematic review and meta‐analysis. Br J Dermatol. 2020;183(2):210‐219. [DOI] [PubMed] [Google Scholar]
- 7. Dinnes J, Deeks JJ, Saleh D, et al. Reflectance confocal microscopy for diagnosing cutaneous melanoma in adults. Cochrane Database Syst Rev. 2018;12(12):CD013190. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8. Pellacani G, Farnetani F, Ciardo S, et al. Effect of Reflectance Confocal Microscopy for Suspect Lesions on Diagnostic Accuracy in Melanoma: A Randomized Clinical Trial. JAMA Dermatol. 2022;158(7):754‐761. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9. Pellacani G, Farnetani F, Chester J, et al. Cutaneous Melanoma Systematic Diagnostic Workflows and Integrated Reflectance Confocal Microscopy Assessed with a Retrospective, Comparative Longitudinal (2009‐2018) Study. Cancers (Basel). 2022;14(3):838. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10. Gonzalez S, Sackstein R, Anderson RR, Rajadhyaksha M. Real‐time evidence of in vivo leukocyte trafficking in human skin by reflectance confocal microscopy. J Invest Dermatol. 2001;117(2):384‐386. [DOI] [PubMed] [Google Scholar]
- 11. Gonzalez S, Tannous Z. Real‐time, in vivo confocal reflectance microscopy of basal cell carcinoma. J Am Acad Dermatol. 2002;47(6):869‐874. [DOI] [PubMed] [Google Scholar]
- 12. Sauermann K, Gambichler T, Wilmert M, et al. Investigation of basal cell carcinoma [correction of carcionoma] by confocal laser scanning microscopy in vivo. Skin Res Technol. 2002;8(3):141‐147. [DOI] [PubMed] [Google Scholar]
- 13. Agero AL, Busam KJ, Benvenuto‐Andrade C, et al. Reflectance confocal microscopy of pigmented basal cell carcinoma. J Am Acad Dermatol. 2006;54(4):638‐643. [DOI] [PubMed] [Google Scholar]
- 14. Braga JC, Scope A, Klaz I, et al. The significance of reflectance confocal microscopy in the assessment of solitary pink skin lesions. J Am Acad Dermatol. 2009;61(2):230‐241. [DOI] [PubMed] [Google Scholar]
- 15. Chung VQ, Dwyer PJ, Nehal KS, et al. Use of ex vivo confocal scanning laser microscopy during Mohs surgery for nonmelanoma skin cancers. Dermatol Surg. 2004;30(12 Pt 1):1470‐1478. [DOI] [PubMed] [Google Scholar]
- 16. Patel YG, Nehal KS, Aranda I, et al. Confocal reflectance mosaicing of basal cell carcinomas in Mohs surgical skin excisions. J Biomed Opt. 2007;12(3):034027. [DOI] [PubMed] [Google Scholar]
- 17. Nori S, Rius‐Diaz F, Cuevas J, et al. Sensitivity and specificity of reflectance‐mode confocal microscopy for in vivo diagnosis of basal cell carcinoma: a multicenter study. J Am Acad Dermatol. 2004;51(6):923‐930. [DOI] [PubMed] [Google Scholar]
- 18. Ulrich M, Roewert‐Huber J, Gonzalez S, et al. Peritumoral clefting in basal cell carcinoma: correlation of in vivo reflectance confocal microscopy and routine histology. J Cutan Pathol. 2011;38(2):190‐195. [DOI] [PubMed] [Google Scholar]
- 19. Aghassi D, Anderson RR, Gonzalez S. Confocal laser microscopic imaging of actinic keratoses in vivo: a preliminary report. J Am Acad Dermatol. 2000;43(1 Pt 1):42‐48. [DOI] [PubMed] [Google Scholar]
- 20. Horn M, Gerger A, Ahlgrimm‐Siess V, et al. Discrimination of actinic keratoses from normal skin with reflectance mode confocal microscopy. Dermatol Surg. 2008;34(5):620‐625. [DOI] [PubMed] [Google Scholar]
- 21. Ulrich M, Maltusch A, Rowert‐Huber J, et al. Actinic keratoses: non‐invasive diagnosis for field cancerisation. Br J Dermatol. 2007;156(Suppl 3):13‐17. [DOI] [PubMed] [Google Scholar]
- 22. Ulrich M, Maltusch A, Rius‐Diaz F, et al. Clinical applicability of in vivo reflectance confocal microscopy for the diagnosis of actinic keratoses. Dermatol Surg. 2008;34(5):610‐619. [DOI] [PubMed] [Google Scholar]
- 23. Pellacani G, Ulrich M, Casari A, et al. Grading keratinocyte atypia in actinic keratosis: a correlation of reflectance confocal microscopy and histopathology. J Eur Acad Dermatol Venereol. 2015;29(11):2216‐2221. [DOI] [PubMed] [Google Scholar]
- 24. Ulrich M, Kanitakis J, Gonzalez S, et al. Evaluation of Bowen disease by in vivo reflectance confocal microscopy. Br J Dermatol. 2012;166(2):451‐453. [DOI] [PubMed] [Google Scholar]
- 25. Rishpon A, Kim N, Scope A, et al. Reflectance confocal microscopy criteria for squamous cell carcinomas and actinic keratoses. Arch Dermatol. 2009;145(7):766‐772. [DOI] [PubMed] [Google Scholar]
- 26. Hoogedoorn L, Peppelman M, van de Kerkhof PC, et al. The value of in vivo reflectance confocal microscopy in the diagnosis and monitoring of inflammatory and infectious skin diseases: a systematic review. Br J Dermatol. 2015;172(5):1222‐1248. [DOI] [PubMed] [Google Scholar]
- 27. Pimenta R, Soares‐de‐Almeida L, Arzberger E, et al. Reflectance confocal microscopy for the diagnosis of skin infections and infestations. Dermatol Online J. 2020;26(3):13030. [PubMed] [Google Scholar]
- 28. Liansheng Z, Xin J, Cheng Q, et al. Diagnostic applicability of confocal laser scanning microscopy in tinea corporis. Int J Dermatol. 2013;52(10):1281‐122. [DOI] [PubMed] [Google Scholar]
- 29. Friedman D, Friedman PC, Gill M. Reflectance confocal microscopy: an effective diagnostic tool for dermatophytic infections. Cutis. 2015;95(2):93‐97. [PubMed] [Google Scholar]
- 30. Turan E, Erdemir AT, Gurel MS, Yurt N. A new diagnostic technique for tinea incognito: in vivo reflectance confocal microscopy. Report of five cases. Skin Res Technol. 2013;19(1):e103‐e107. [DOI] [PubMed] [Google Scholar]
- 31. Navarrete‐Dechent C, Bajaj S, Marghoob AA, Marchetti MA. Rapid diagnosis of tinea incognito using handheld reflectance confocal microscopy: a paradigm shift in dermatology? Mycoses. 2015;58(6):383‐836. [DOI] [PubMed] [Google Scholar]
- 32. Rothmund G, Sattler EC, Kaestle R, et al. Confocal laser scanning microscopy as a new valuable tool in the diagnosis of onychomycosis ‐ comparison of six diagnostic methods. Mycoses. 2013;56(1):47‐55. [DOI] [PubMed] [Google Scholar]
- 33. Pharaon M, Gari‐Toussaint M, Khemis A, et al. Diagnosis and treatment monitoring of toenail onychomycosis by reflectance confocal microscopy: prospective cohort study in 58 patients. J Am Acad Dermatol. 2014;71(1):56‐61. [DOI] [PubMed] [Google Scholar]
- 34. Wang ZY, Fei WM, Li CX, Cui Y. Comparison of dermoscopy and reflectance confocal microscopy accuracy for the diagnosis of psoriasis and lichen planus. Skin Res Technol. 2022;28(3):480‐486. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35. Levi A, Mumcuoglu KY, Ingber A, Enk CD. Assessment of Sarcoptes scabiei viability in vivo by reflectance confocal microscopy. Lasers Med Sci. 2011;26(3):291‐292. [DOI] [PubMed] [Google Scholar]
- 36. Longo C, Bassoli S, Monari P, et al. Reflectance‐mode confocal microscopy for the in vivo detection of Sarcoptes scabiei. Arch Dermatol. 2005;141(10):1336. [DOI] [PubMed] [Google Scholar]
- 37. Cinotti E, Labeille B, Cambazard F, et al. Videodermoscopy compared to reflectance confocal microscopy for the diagnosis of scabies. J Eur Acad Dermatol Venereol. 2016;30(9):1573‐1577. [DOI] [PubMed] [Google Scholar]
- 38. Sattler EC, Hoffmann VS, Ruzicka T, et al. Reflectance confocal microscopy for monitoring the density of Demodex mites in patients with rosacea before and after treatment. Br J Dermatol. 2015;173(1):69‐75. [DOI] [PubMed] [Google Scholar]
- 39. Sattler EC, Maier T, Hoffmann VS, et al. Noninvasive in vivo detection and quantification of Demodex mites by confocal laser scanning microscopy. Br J Dermatol. 2012;167(5):1042‐1047. [DOI] [PubMed] [Google Scholar]
- 40. Wang YJ, Ke M, Chen XM. Prospective Study of the Diagnostic Accuracy of the In Vivo Laser Scanning Confocal Microscopy for Ocular Demodicosis. Am J Ophthalmol. 2019;203:46‐52. [DOI] [PubMed] [Google Scholar]
- 41. Agozzino M, Berardesca E, Donadio C, et al. Reflectance confocal microscopy features of seborrheic dermatitis for plaque psoriasis differentiation. Dermatology. 2014;229(3):215‐221. [DOI] [PubMed] [Google Scholar]
- 42. Ardigo M, Longo C, Gonzalez S, International Confocal Working Group Inflammatory Skin Diseases P. Multicentre study on inflammatory skin diseases from The International Confocal Working Group: specific confocal microscopy features and an algorithmic method of diagnosis. Br J Dermatol. 2016;175(2):364‐374. [DOI] [PubMed] [Google Scholar]
- 43. Swindells K, Burnett N, Rius‐Diaz F, et al. Reflectance confocal microscopy may differentiate acute allergic and irritant contact dermatitis in vivo. J Am Acad Dermatol. 2004;50(2):220‐228. [DOI] [PubMed] [Google Scholar]
- 44. Astner S, Gonzalez S, Gonzalez E. Noninvasive evaluation of allergic and irritant contact dermatitis by in vivo reflectance confocal microscopy. Dermatitis. 2006;17(4):182‐191. [DOI] [PubMed] [Google Scholar]
- 45. Maarouf M, Costello CM, Gonzalez S, et al. In Vivo Reflectance Confocal Microscopy: Emerging Role in Noninvasive Diagnosis and Monitoring of Eczematous Dermatoses. Actas Dermosifiliogr (Engl Ed). 2019;110(8):626‐636. [DOI] [PubMed] [Google Scholar]
- 46. Benjamin B, Chris F, Salvador G, et al. Visual and confocal microscopic interpretation of patch tests to benzethonium chloride and benzalkonium chloride. Skin Res Technol. 2012;18(3):272‐277. [DOI] [PubMed] [Google Scholar]
- 47. Sakanashi EN, Matsumura M, Kikuchi K, et al. A comparative study of allergic contact dermatitis by patch test versus reflectance confocal laser microscopy, with nickel and cobalt. Eur J Dermatol. 2010;20(6):705‐711. [DOI] [PubMed] [Google Scholar]
- 48. Astner S, Gonzalez E, Cheung AC, et al. Non‐invasive evaluation of the kinetics of allergic and irritant contact dermatitis. J Invest Dermatol. 2005;124(2):351‐359. [DOI] [PubMed] [Google Scholar]
- 49. Hartmann D. [Ex vivo confocal laser scanning microscopy for melanocytic lesions and autoimmune diseases]. Hautarzt. 2021;72(12):1058‐1065. [DOI] [PubMed] [Google Scholar]
- 50. Malvehy J, Perez‐Anker J, Toll A, et al. Ex vivo confocal microscopy: revolution in fast pathology in dermatology. Br J Dermatol. 2020;183(6):1011‐1025. [DOI] [PubMed] [Google Scholar]
- 51. Pérez‐Anker J, Puig S, Malvehy J. A fast and effective option for tissue flattening: Optimizing time and efficacy in ex vivo confocal microscopy. J Am Acad Dermatol. 2020;82(5):e157‐e158. [DOI] [PubMed] [Google Scholar]
- 52. Welzel J. Reflectance confocal microscopy: new micromorphological insights into inflammatory skin diseases. Br J Dermatol. 2016;175(2):239‐240. [DOI] [PubMed] [Google Scholar]
- 53. Hartmann D, Ruini C, Mathemeier L, et al. Identification of ex‐vivo confocal laser scanning microscopic features of melanocytic lesions and their histological correlates. J Biophotonics. 2017;10(1):128‐142. [DOI] [PubMed] [Google Scholar]
- 54. Longo C, Rajadhyaksha M, Ragazzi M, et al. Evaluating ex vivo fluorescence confocal microscopy images of basal cell carcinomas in Mohs excised tissue. Br J Dermatol. 2014;171(3):561‐570. [DOI] [PubMed] [Google Scholar]
- 55. Hartmann D, Krammer S, Bachmann MR, et al. Ex vivo confocal microscopy features of cutaneous squamous cell carcinoma. J Biophotonics. 2018;11(4):e201700318. [DOI] [PubMed] [Google Scholar]
- 56. Bini J, Spain J, Nehal K, et al. Confocal mosaicing microscopy of human skin ex vivo: spectral analysis for digital staining to simulate histology‐like appearance. J Biomed Opt. 2011;16(7):076008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57. Mentzel J, Anderegg U, Paasch U, et al. 'Retraction artefacts' in basal cell carcinomas do not result from fixation but likely arise by degradation of extracellular matrix during tumour growth. J Eur Acad Dermatol Venereol. 2022;36(3):e244‐e247. [DOI] [PubMed] [Google Scholar]
- 58. Longo C, Pampena R, Bombonato C, et al. Diagnostic accuracy of ex vivo fluorescence confocal microscopy in Mohs surgery of basal cell carcinomas: a prospective study on 753 margins. Br J Dermatol. 2019;180(6):1473‐1480. [DOI] [PubMed] [Google Scholar]
- 59. Peters N, Schubert M, Metzler G, et al. Diagnostic accuracy of a new ex vivo confocal laser scanning microscope compared to H&E‐stained paraffin slides for micrographic surgery of basal cell carcinoma. J Eur Acad Dermatol Venereol. 2019;33(2):298‐304. [DOI] [PubMed] [Google Scholar]
- 60. Grupp M, Illes M, Mentzel J, et al. Routine application of ex vivo confocal laser scanning microscopy with digital staining for examination of surgical margins in basal cell carcinomas. J Dtsch Dermatol Ges. 2021;19(5):685‐692. [DOI] [PubMed] [Google Scholar]
- 61. Bennàssar A, Vilata A, Puig S, Malvehy J. Ex vivo fluorescence confocal microscopy for fast evaluation of tumour margins during Mohs surgery. Br J Dermatol. 2014;170(2):360‐365. [DOI] [PubMed] [Google Scholar]
- 62. Vladimirova G, Ruini C, Kapp F, et al. Ex vivo confocal laser scanning microscopy: A diagnostic technique for easy real‐time evaluation of benign and malignant skin tumours. J Biophotonics. 2022;15(6):e202100372. [DOI] [PubMed] [Google Scholar]
- 63. Ackermann BAB, Almut, Bennin B, Gottlieb, Geoffrey J. Histologic Diagnosis Of Inflammatory Skin Diseases: An Algorithmic Method Based On Pattern Analysis: New York: Ardor Scribendi, 2005. [Google Scholar]
- 64. Mentzel J, Stecher MM, Paasch U, et al. Ex vivo confocal laser scanning microscopy with digital staining is able to map characteristic histopathological features and tissue reaction patterns of inflammatory skin diseases. J Eur Acad Dermatol Venereol. 2021;35(4):e263‐e265. [DOI] [PubMed] [Google Scholar]
- 65. Bagci IS, Ergun EZ, Avci P, et al. Indirect immunofluorescence for bullous pemphigoid using ex vivo confocal laser scanning microscopy. J Dermatol. 2023;50(8):e236‐e237. [DOI] [PubMed] [Google Scholar]
- 66. Hartmann D. Ex vivo konfokale Laserscanmikroskopie – die neue Bedside‐Histologie. Aktuelle Dermatologie. 2020;46(04):152‐157. [Google Scholar]
- 67. Pérez‐Anker J, Toll A, Puig S, Malvehy J. Six steps to reach optimal scanning in ex vivo confocal microscopy. J Am Acad Dermatol. 2022;86(1):188‐189. [DOI] [PubMed] [Google Scholar]
- 68. Hartmann D, Ruini C, Mathemeier L, et al. Identification of ex‐vivo confocal scanning microscopic features and their histological correlates in human skin. J Biophotonics. 2016;9(4):376‐387. [DOI] [PubMed] [Google Scholar]
- 69. Combalia M, Garcia S, Malvehy J, et al. Deep learning automated pathology in ex vivo microscopy. Biomed Opt Express. 2021;12(6):3103‐3116. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 70. Ruini C, Vladimirova G, Kendziora B, et al. Ex‐vivo fluorescence confocal microscopy with digital staining for characterizing basal cell carcinoma on frozen sections: A comparison with histology. J Biophotonics. 2021;14(8):e202100094. [DOI] [PubMed] [Google Scholar]
- 71. Hartmann D. [Artificial intelligence in ex vivo confocal laser scanning microscopy]. Hautarzt. 2021;72(12):1066‐1070. [DOI] [PubMed] [Google Scholar]
- 72. von Braunmuhl T. [Optical coherence tomography]. Hautarzt. 2015;66(7):499‐503. [DOI] [PubMed] [Google Scholar]
- 73. Welzel J. Optical coherence tomography in dermatology: a review. Skin Res Technol. 2001;7(1):1‐9. [DOI] [PubMed] [Google Scholar]
- 74. Sattler E, Kastle R, Welzel J. Optical coherence tomography in dermatology. J Biomed Opt. 2013;18(6):061224. [DOI] [PubMed] [Google Scholar]
- 75. Schuh S, Holmes J, Ulrich M, et al. Imaging Blood Vessel Morphology in Skin: Dynamic Optical Coherence Tomography as a Novel Potential Diagnostic Tool in Dermatology. Dermatol Ther (Heidelb). 2017;7(2):187‐202. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 76. Fuchs CSK, Ortner VK, Mogensen M, et al. 2021 international consensus statement on optical coherence tomography for basal cell carcinoma: image characteristics, terminology and educational needs. J Eur Acad Dermatol Venereol. 2022;36(6):772‐778. [DOI] [PubMed] [Google Scholar]
- 77. Boone MA, Suppa M, Pellacani G, et al. High‐definition optical coherence tomography algorithm for discrimination of basal cell carcinoma from clinical BCC imitators and differentiation between common subtypes. J Eur Acad Dermatol Venereol. 2015;29(9):1771‐80. [DOI] [PubMed] [Google Scholar]
- 78. Heppt MV, Leiter U, Steeb T, et al. S3 guideline for actinic keratosis and cutaneous squamous cell carcinoma ‐ short version, part 1: diagnosis, interventions for actinic keratoses, care structures and quality‐of‐care indicators. J Dtsch Dermatol Ges. 2020;18(3):275‐294. [DOI] [PubMed] [Google Scholar]
- 79. Friis KBE, Themstrup L, Jemec GBE. Optical coherence tomography in the diagnosis of actinic keratosis‐A systematic review. Photodiagnosis Photodyn Ther. 2017;18:98‐104. [DOI] [PubMed] [Google Scholar]
- 80. Marneffe A, Suppa M, Miyamoto M, et al. Validation of a diagnostic algorithm for the discrimination of actinic keratosis from normal skin and squamous cell carcinoma by means of high‐definition optical coherence tomography. Exp Dermatol. 2016;25(9):684‐687. [DOI] [PubMed] [Google Scholar]
- 81. Rajabi‐Estarabadi A, Bittar JM, Zheng C, et al. Optical coherence tomography imaging of melanoma skin cancer. Lasers Med Sci. 2019;34(2):411‐420. [DOI] [PubMed] [Google Scholar]
- 82. Wan B, Ganier C, Du‐Harpur X, et al. Applications and future directions for optical coherence tomography in dermatology. Br J Dermatol. 2021;184(6):1014‐1022. [DOI] [PubMed] [Google Scholar]
- 83. Welzel J, Schuh S, De Carvalho N, et al. Dynamic optical coherence tomography shows characteristic alterations of blood vessels in malignant melanoma. J Eur Acad Dermatol Venereol. 2021;35(5):1087‐1093. [DOI] [PubMed] [Google Scholar]
- 84. De Carvalho N, Welzel J, Schuh S, et al. The vascular morphology of melanoma is related to Breslow index: An in vivo study with dynamic optical coherence tomography. Exp Dermatol. 2018;27(11):1280‐1286. [DOI] [PubMed] [Google Scholar]
- 85. Ruini C, Schuh S, Gust C, et al. Line‐field optical coherence tomography: In vivo diagnosis of basal cell carcinoma subtypes compared to histopathology. Clin Exp Dermatol. 2021;46(8):1471‐1481. [DOI] [PubMed] [Google Scholar]
- 86. Gust C, Schuh S, Welzel J, et al. Line‐Field Confocal Optical Coherence Tomography Increases the Diagnostic Accuracy and Confidence for Basal Cell Carcinoma in Equivocal Lesions: A Prospective Study. Cancers (Basel). 2022;14(4). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 87. Suppa M, Fontaine M, Dejonckheere G, et al. Line‐field confocal optical coherence tomography of basal cell carcinoma: a descriptive study. J Eur Acad Dermatol Venereol. 2021;35(5):1099‐1110. [DOI] [PubMed] [Google Scholar]
- 88. Ruini C, Schuh S, Gust C, et al. Line‐field confocal optical coherence tomography for the in‐vivo real‐time diagnosis of different stages of keratinocyte skin cancer: a preliminary study. J Eur Acad Dermatol Venereol. 2021;35(12):2388‐2397. [DOI] [PubMed] [Google Scholar]
- 89. Cinotti E, Bertello M, Cartocci A, et al. Comparison of reflectance confocal microscopy and line‐field optical coherence tomography for the identification of keratinocyte skin tumours. Skin Res Technol. 2023;29(1):e13215. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 90. Lenoir C, Cinotti E, Tognetti L, et al. Line‐field confocal optical coherence tomography of actinic keratosis: a case series. J Eur Acad Dermatol Venereol. 2021;35(12):e900‐e902. [DOI] [PubMed] [Google Scholar]
- 91. Ruini C, Schuh S, Gust C, et al. In‐Vivo LC‐OCT Evaluation of the Downward Proliferation Pattern of Keratinocytes in Actinic Keratosis in Comparison with Histology: First Impressions from a Pilot Study. Cancers (Basel). 2021;13(12). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 92. Lenoir C, Perez‐Anker J, Diet G, et al. Line‐field confocal optical coherence tomography of benign dermal melanocytic proliferations: a case series. J Eur Acad Dermatol Venereol. 2021;35(6):e399‐e401. [DOI] [PubMed] [Google Scholar]
- 93. Schuh S, Ruini C, Perwein MKE, et al. Line‐Field Confocal Optical Coherence Tomography: A New Tool for the Differentiation between Nevi and Melanomas? Cancers (Basel). 2022;14(5). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 94. Ruini C, Schuh S, Sattler E, Welzel J. Line‐field confocal optical coherence tomography‐Practical applications in dermatology and comparison with established imaging methods. Skin Res Technol. 2021;27(3):340‐352. [DOI] [PubMed] [Google Scholar]
- 95. Perez‐Anker J, Puig S, Alos L, et al. Morphological evaluation of melanocytic lesions with three‐dimensional line‐field confocal optical coherence tomography: correlation with histopathology and reflectance confocal microscopy. A pilot study. Clin Exp Dermatol. 2022;47(12):2222‐2233. [DOI] [PubMed] [Google Scholar]
- 96. Tognetti L, Cinotti E, Suppa M, et al. Line field confocal optical coherence tomography: An adjunctive tool in the diagnosis of autoimmune bullous diseases. J Biophotonics. 2021;14(5):e202000449. [DOI] [PubMed] [Google Scholar]
- 97. Tognetti L, Cinotti E, Falcinelli F, et al. Line‐field confocal optical coherence tomography: a new tool for non‐invasive differential diagnosis of pustular skin disorders. J Eur Acad Dermatol Venereol. 2022;36(10):1873‐1883. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 98. Verzì AE, Broggi G, Micali G, et al. Line‐field confocal optical coherence tomography of psoriasis, eczema and lichen planus: a case series with histopathological correlation. J Eur Acad Dermatol Venereol. 2022;36(10):1884‐1889. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 99. Tsai TH, Jee SH, Dong CY, Lin SJ. Multiphoton microscopy in dermatological imaging. J Dermatol Sci. 2009;56(1):1‐8. [DOI] [PubMed] [Google Scholar]
- 100. Zieger M, Springer S, Koehler MJ, Kaatz M. [Multiphoton tomography]. Hautarzt. 2015;66(7):511‐521. [DOI] [PubMed] [Google Scholar]
- 101. Konig K. Clinical multiphoton tomography. J Biophotonics. 2008;1(1):13‐23. [DOI] [PubMed] [Google Scholar]
- 102. Konig K. Review: Clinical in vivo multiphoton FLIM tomography. Methods Appl Fluoresc. 2020;8(3):034002. [DOI] [PubMed] [Google Scholar]
- 103. Klemp M, Meinke MC, Weinigel M, et al. Comparison of morphologic criteria for actinic keratosis and squamous cell carcinoma using in vivo multiphoton tomography. Exp Dermatol. 2016;25(3):218‐222. [DOI] [PubMed] [Google Scholar]
- 104. Koehler MJ, Kellner K, Hipler UC, Kaatz M. Acute UVB‐induced epidermal changes assessed by multiphoton laser tomography. Skin Res Technol. 2015;21(2):137‐143. [DOI] [PubMed] [Google Scholar]
- 105. Koehler MJ, Vogel T, Elsner P, et al. In vivo measurement of the human epidermal thickness in different localizations by multiphoton laser tomography. Skin Res Technol. 2010;16(3):259‐264. [DOI] [PubMed] [Google Scholar]
- 106. Paoli J, Smedh M, Ericson MB. Multiphoton laser scanning microscopy–a novel diagnostic method for superficial skin cancers. Semin Cutan Med Surg. 2009;28(3):190‐195. [DOI] [PubMed] [Google Scholar]
- 107. Paoli J, Smedh M, Wennberg AM, Ericson MB. Multiphoton laser scanning microscopy on non‐melanoma skin cancer: morphologic features for future non‐invasive diagnostics. J Invest Dermatol. 2008;128(5):1248‐1255. [DOI] [PubMed] [Google Scholar]
- 108. Manfredini M, Arginelli F, Dunsby C, et al. High‐resolution imaging of basal cell carcinoma: a comparison between multiphoton microscopy with fluorescence lifetime imaging and reflectance confocal microscopy. Skin Res Technol. 2013;19(1):e433‐e443. [DOI] [PubMed] [Google Scholar]
- 109. Seidenari S, Arginelli F, Dunsby C, et al. Multiphoton laser tomography and fluorescence lifetime imaging of basal cell carcinoma: morphologic features for non‐invasive diagnostics. Exp Dermatol. 2012;21(11):831‐836. [DOI] [PubMed] [Google Scholar]
- 110. Dimitrow E, Ziemer M, Koehler MJ, et al. Sensitivity and specificity of multiphoton laser tomography for in vivo and ex vivo diagnosis of malignant melanoma. J Invest Dermatol. 2009;129(7):1752‐1758. [DOI] [PubMed] [Google Scholar]
- 111. Meng X, Chen J, Zhang Z, et al. Non‐invasive optical methods for melanoma diagnosis. Photodiagnosis Photodyn Ther. 2021;34:102266. [DOI] [PubMed] [Google Scholar]
- 112. Arginelli F, Manfredini M, Bassoli S, et al. High resolution diagnosis of common nevi by multiphoton laser tomography and fluorescence lifetime imaging. Skin Res Technol. 2013;19(2):194‐204. [DOI] [PubMed] [Google Scholar]
- 113. Seidenari S, Arginelli F, Dunsby C, et al. Multiphoton laser tomography and fluorescence lifetime imaging of melanoma: morphologic features and quantitative data for sensitive and specific non‐invasive diagnostics. PLoS One. 2013;8(7):e70682. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 114. Huck V, Gorzelanny C, Thomas K, et al. From morphology to biochemical state ‐ intravital multiphoton fluorescence lifetime imaging of inflamed human skin. Sci Rep. 2016;6:22789. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 115. König K, Breunig HG, Batista A, et al. Translation of two‐photon microscopy to the clinic: multimodal multiphoton CARS tomography of in vivo human skin. J Biomed Opt. 2020;25(1):1‐12. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 116. Guimaraes P, Batista A, Zieger M, et al. Artificial Intelligence in Multiphoton Tomography: Atopic Dermatitis Diagnosis. Sci Rep. 2020;10(1):7968. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 117. Chia TH, Williamson A, Spencer DD, Levene MJ. Multiphoton fluorescence lifetime imaging of intrinsic fluorescence in human and rat brain tissue reveals spatially distinct NADH binding. Opt Express. 2008;16(6):4237‐4249. [DOI] [PubMed] [Google Scholar]
- 118. Niesner R, Narang P, Spiecker H, et al. Selective detection of NADPH oxidase in polymorphonuclear cells by means of NAD(P)H‐based fluorescence lifetime imaging. J Biophys. 2008;2008:602639. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 119. Vishwasrao HD, Heikal AA, Kasischke KA, Webb WW. Conformational dependence of intracellular NADH on metabolic state revealed by associated fluorescence anisotropy. J Biol Chem. 2005;280(26):25119‐25126. [DOI] [PubMed] [Google Scholar]
- 120. Wolberink EA, van Erp PE, de Boer‐van Huizen RT, et al. Reflectance confocal microscopy: an effective tool for monitoring ultraviolet B phototherapy in psoriasis. Br J Dermatol. 2012;167(2):396‐403. [DOI] [PubMed] [Google Scholar]
- 121. Kapsokalyvas D, Cicchi R, Bruscino N, et al. In‐vivo imaging of psoriatic lesions with polarization multispectral dermoscopy and multiphoton microscopy. Biomed Opt Express. 2014;5(7):2405‐2419. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 122. Zurauskas M, Barkalifa R, Alex A, et al. Assessing the severity of psoriasis through multivariate analysis of optical images from non‐lesional skin. Sci Rep. 2020;10(1):9154. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 123. König K, Batista A, König A, Breunig HG. Multimodal multiphoton tomograph using a compact femtosecond fiber laser. SPIE. 2019;10882. [Google Scholar]
- 124. König K, Batista A, Zieger M, et al. Clinical multimodal multiphoton tomography of pigmented skin lesions with an ultracompact femtosecond fiber laser. SPIE. 2020;11211. [Google Scholar]
- 125. Messas T, Messas A, Kroumpouzos G. Optoacoustic imaging and potential applications of raster‐scan optoacoustic mesoscopy in dermatology. Clin Dermatol. 2021;40(1):85‐92. [DOI] [PubMed] [Google Scholar]
- 126. Attia ABE, Balasundaram G, Moothanchery M, et al. A review of clinical photoacoustic imaging: Current and future trends. Photoacoustics. 2019;16:100144. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 127. Nau T, Schneider S, Aguirre J, et al. [Optoacoustic imaging‐Applications and advancements of innovative imaging techniques]. Hautarzt. 2021;72(12):1025‐1038. [DOI] [PubMed] [Google Scholar]
- 128. Omar M, Aguirre J, Ntziachristos V. Optoacoustic mesoscopy for biomedicine. Nat Biomed Eng. 2019;3(5):354‐370. [DOI] [PubMed] [Google Scholar]
- 129. He H, Schonmann C, Schwarz M, et al. Fast raster‐scan optoacoustic mesoscopy enables assessment of human melanoma microvasculature in vivo. Nat Commun. 2022;13(1):2803. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 130. Hindelang B, Nau T, Englert L, et al. Enabling precision monitoring of psoriasis treatment by optoacoustic mesoscopy. Sci Transl Med. 2022;14(644):eabm8059. [DOI] [PubMed] [Google Scholar]
- 131. Li X, Moothanchery M, Kwa CY, et al. Multispectral raster‐scanning optoacoustic mesoscopy differentiate lesional from non‐lesional atopic dermatitis skin using structural and functional imaging markers. Photoacoustics. 2022;28:100399. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 132. Yew YW, Dinish US, Choi ECE, et al. Investigation of morphological, vascular and biochemical changes in the skin of an atopic dermatitis (AD) patient in response to dupilumab using raster scanning optoacoustic mesoscopy (RSOM) and handheld confocal Raman spectroscopy (CRS). J Dermatol Sci. 2019;95(3):123‐125. [DOI] [PubMed] [Google Scholar]
- 133. Chuah SY, Attia ABE, Ho CJH, et al. Volumetric Multispectral Optoacoustic Tomography for 3‐Dimensional Reconstruction of Skin Tumors: A Further Evaluation with Histopathologic Correlation. J Invest Dermatol. 2019;139(2):481‐485. [DOI] [PubMed] [Google Scholar]
- 134. Wong TTW, Zhang R, Hai P, et al. Fast label‐free multilayered histology‐like imaging of human breast cancer by photoacoustic microscopy. Sci Adv. 2017;3(5):e1602168. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 135. Zhang D, Yuan Y, Zhang H, et al. Photoacoustic Microscopy Provides Early Prediction of Tissue Necrosis in Skin Avulsion Injuries. Clin Cosmet Investig Dermatol. 2021;14:837‐844. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 136. Rebling J, Ben‐Yehuda Greenwald M, Wietecha M, et al. Long‐Term Imaging of Wound Angiogenesis with Large Scale Optoacoustic Microscopy. Adv Sci (Weinh). 2021;8(13):2004226. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 137. Monheit G, Cognetta AB, Ferris L, et al. The performance of MelaFind: a prospective multicenter study. Arch Dermatol. 2011;147(2):188‐194. [DOI] [PubMed] [Google Scholar]
- 138. Elbaum M, Kopf AW, Rabinovitz HS, et al. Automatic differentiation of melanoma from melanocytic nevi with multispectral digital dermoscopy: a feasibility study. J Am Acad Dermatol. 2001;44(2):207‐218. [DOI] [PubMed] [Google Scholar]
- 139. Tomatis S, Carrara M, Bono A, et al. Automated melanoma detection with a novel multispectral imaging system: results of a prospective study. Phys Med Biol. 2005;50(8):1675‐1687. [DOI] [PubMed] [Google Scholar]
- 140. Bozsanyi S, Varga NN, Farkas K, et al. Multispectral Imaging Algorithm Predicts Breslow Thickness of Melanoma. J Clin Med. 2021;11(1). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 141. Griffiths P, Lewis, I. , Chaffin, N. , Jegla, J . Remote characterization of Materials by vibrational spectrometry through optical fibers. Journal of Molecular Structure. 1995;347:169‐185. [Google Scholar]
- 142. Saar BG, Freudiger CW, Reichman J, et al. Video‐rate molecular imaging in vivo with stimulated Raman scattering. Science. 2010;330(6009):1368‐1370. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 143. Schneider SL, Kohli I, Hamzavi IH, et al. Emerging imaging technologies in dermatology: Part I: Basic principles. J Am Acad Dermatol. 2019;80(4):1114‐1120. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 144. Schneider SL, Kohli I, Hamzavi IH, et al. Emerging imaging technologies in dermatology: Part II: Applications and limitations. J Am Acad Dermatol. 2019;80(4):1121‐1131. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 145. Pyun SH, Min W, Goo B, et al. Real‐time, in vivo skin cancer triage by laser‐induced plasma spectroscopy combined with a deep learning‐based diagnostic algorithm. J Am Acad Dermatol. 2023;89(1):99‐105. [DOI] [PubMed] [Google Scholar]
